Percutaneous Cholangiopancreatoscopy Registry
Launched by JOHNS HOPKINS UNIVERSITY · Jan 13, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Percutaneous Cholangiopancreatoscopy (PCPS) Registry is a study aimed at understanding the experiences of patients who have undergone a specific procedure called percutaneous cholangiopancreatoscopy. This procedure is used to treat conditions related to the bile ducts and pancreas, such as biliary stones and strictures. The study involves collecting information about patients from hospitals across the United States, both from past records and during their upcoming visits for treatment over the next three years.
To be eligible for this study, participants must be adults aged 18 or older who are scheduled for the cholangiopancreatoscopy procedure at a participating hospital, like Johns Hopkins. They should also be able to understand and sign a consent form. Unfortunately, pregnant women and children cannot take part in this study. Participants can expect to share their medical information during their hospital visits, helping researchers learn more about this important procedure and improve care for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male or female adults
- • 18 years of age and older
- • Patients undergoing clinically indicated percutaneous cholangiopancreatoscopy procedure at the Johns Hopkins Hospital or one of the registry sites.
- • Willing and able to understand and sign a written informed consent document for the prospective component of the study.
- Exclusion Criteria:
- • Pregnant women
- • Children (\< 18 years of age)
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Patients applied
Trial Officials
Harjit Singh, MD
Principal Investigator
Johns Hopkins University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials